Alignment Healthcare insider files to sell 69,541 shares

Alignment Healthcare, Inc. notice of sale of 69,541 shares of Common Stock.

Accepted by SEC EDGAR 03/10/2026 - 07:32 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Alignment Healthcare, Inc. notice of sale of 69,541 shares of Common Stock. The filing lists the sale date as 12/29/2025 and an aggregate transaction amount of $1,303,384.48.

The shares were acquired on 03/08/2022 upon vesting of restricted stock units granted under the 2021 Equity Incentive Plan. The filing identifies the seller as Robert L. Scavo.

Insights

Securities Compliance Analyst

Routine Form 144 resale by an insider reporting vested RSU shares.

The filing documents a proposed sale of 69,541 shares of Common Stock on 12/29/2025 with an aggregate value of $1,303,384.48. It states these shares were acquired on 03/08/2022 via RSU vesting under the 2021 Equity Incentive Plan.

Regulatory implications are procedural: this notice reflects a Rule 144 sale filing rather than a company action. Cash‑flow treatment indicates proceeds to the selling holder; the filing names Robert L. Scavo as the seller.

Corporate Governance Advisor

Insider disposition consistent with compensation vesting and routine liquidity.

The shares shown were acquired at vesting on 03/08/2022 and are listed for resale in the Form 144. The filing does not state any company receipt of proceeds.

Investor impact is typically limited for single‑holder Rule 144 notices; subsequent SEC filings or trading reports would show executed sales and any effect on outstanding shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Alignment Healthcare (ALHC) Form 144 report?

It reports a proposed resale of 69,541 shares by an insider on 12/29/2025. The filing shows an aggregate value of $1,303,384.48 and identifies the seller as Robert L. Scavo.

Were the shares sold by ALHC acquired from compensation?

Yes, the shares were acquired upon the vesting of restricted stock units on 03/08/20222021 Equity Incentive Plan according to the filing.

Does the Form 144 indicate who receives the sale proceeds for ALHC?

The filing indicates proceeds relate to the selling holder rather than the issuer. It names Robert L. Scavo as the seller; the company is not listed as receiving proceeds.

Is a Form 144 an executed sale or a notice for ALHC?

Form 144 is a notice of intent to sell shares under Rule 144, not proof of completed sale. Execution and trade details would appear in subsequent transaction reports or market records.

How many shares were acquired versus listed for sale in the ALHC filing?

The filing shows the shares were acquired on 03/08/2022> via RSU vesting; it lists 69,541 shares proposed for resale on 12/29/2025 with no aggregate breakdown beyond the stated value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001975024
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Alignment Healthcare, Inc.
SEC File Number	001-40295
Address of Issuer	1100 W. Town & Country Road Suite 1600 Orange CALIFORNIA 92868
Phone	844-310-2247
Name of Person for Whose Account the Securities are To Be Sold	Robert L. Scavo
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Chief Information Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	E-Trade Finance PO Box 101600 Arlington VA 22210-4600	4100	75604	204296493	03/11/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/08/2022	The Common Stock was acquired through the vesting of restricted stock units granted on 03/08/2022 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			12417	03/08/2022	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert L. Scavo 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	12/29/2025	69541	1303384.48

144: Remarks and Signature

Remarks	Shares sold pursuant to a sale-to-cover transaction and does not represent a discretionary trade by the reporting person. Actual number of shares sold will be determined based on applicable tax withholding rates and stock price at the time of sale.
Date of Notice	03/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Robert L. Scavo
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)